Since the epidermis overlying cNF is normal, "there is no reason to use nonselective or surgical methods and destroy a perfectly good epidermis when you don t need to," Patricia Richey, MD, said.
Combining Moderna s patient-specific mRNA-based cancer vaccine with pembrolizumab may prolong recurrence-free survival in patients with high-risk melanoma vs pembrolizumab alone, new data show.
The results "support the need for prospective randomized clinical trials to definitively answer the important question about appropriate excision margins for T1a melanoma," the investigators write.
I think what we have learned is that if you ever thought that mRNA was just for infectious diseases, or just for COVID, the evidence now is that s absolutely not the case, said Moderna CMO Paul Burton.